Unlock instant, AI-driven research and patent intelligence for your innovation.

Chitosan hemostatic material formed through covalent crosslinking and preparation method thereof

A technology of covalently cross-linked and hemostatic materials, which is applied in the fields of pharmaceutical formulation, application, and medical science, can solve problems such as not being able to fully meet clinical needs, and achieve low production costs, safe cross-linking agents, and simple and easy preparation processes Effect

Active Publication Date: 2015-04-01
LANZHOU KAIBO PHARMA
View PDF12 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] In summary, judging from the currently disclosed chitosan hemostatic material preparation technology, due to various reasons, it cannot fully meet the clinical needs.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Chitosan hemostatic material formed through covalent crosslinking and preparation method thereof
  • Chitosan hemostatic material formed through covalent crosslinking and preparation method thereof
  • Chitosan hemostatic material formed through covalent crosslinking and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0030] A preparation method of chitosan hemostatic material formed by covalent crosslinking, the steps are as follows:

[0031] 1) Chitosan is made into an aqueous solution;

[0032] 2) Add the cross-linking agent into the chitosan aqueous solution, stir and mix thoroughly, then pour into the mold and dry;

[0033] The crosslinking agent is 1,4-butanediol diglycidyl ether.

[0034] The molar ratio of 1,4-butanediol diglycidyl ether to the monosaccharide unit in the chitosan molecule is 0.001:1-1:1; preferably, it is 0.05:1 or 0.10:1 or 0.20:1. The determination of the molar amount of monosaccharide units in a chitosan molecule is common knowledge.

[0035] The chitosan solution is an aqueous solution of chitosan formulated with an aqueous solution, an aqueous solution containing an organic solvent, or an aqueous acid solution, wherein the acid used is an organic acid and an inorganic acid; preferably, it is an aqueous acid solution; more preferably, it is Aqueous solution o...

Embodiment 1

[0042]Weigh chitosan (viscosity 100mPa s, degree of deacetylation 90%) (0.34g, molar weight of monosaccharide unit is 21.2mmol) dissolved in 2% acetic acid solution (v / v, 17ml) to obtain 2% chitosan Sugar solution (w / v), shaking at 40°C for 24 hours to dissolve completely. Add 1,4-butanediol diglycidyl ether (21.3mg, 0.05eq), stir mechanically, pour into a mold with a diameter of 6cm and let it stand for 12h, freeze-dry to obtain a sponge-like product with a thickness of 5mm.

Embodiment 2

[0044] The procedure is exactly the same as in Example 1, except that the amount of 1,4-butanediol diglycidyl ether added is 42.6 mg, (0.10 eq).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a chitosan hemostatic material formed through covalent crosslinking and a preparation method thereof. The chitosan hemostatic material formed through covalent crosslinking is obtained by covalently crosslinking chitosan by utilizing a crosslinking agent, wherein the crosslinking agent is 1,4-butanediol diglycidyl ether. The preparation method of the chitosan hemostatic material formed through covalent crosslinking comprises the following steps: 1) preparing chitosan into a water solution; 2) adding the crosslinking agent to the chitosan water solution, fully stirring and mixing the materials, then pouring the mixture into a mold, and drying the product, thus obtaining the chitosan hemostatic material, wherein the crosslinking agent is 1,4-butanediol diglycidyl ether. The chitosan hemostatic material and the preparation method have the beneficial effects that chitosan is crosslinked by 1,4-butanediol diglycidyl ether under acidic conditions; an ethylene oxide group in 1,4-butanediol diglycidyl ether carries out ring-opening reaction with hydroxyl on chitosan under acidic conditions to form the crosslinked product by generating ether bonds; the crosslinking agent used in the method is relatively safe; the preparation process is simple and practicable and is lower in production cost.

Description

technical field [0001] The invention relates to a chitosan hemostatic material formed by covalent crosslinking and a preparation method thereof. Background technique [0002] Bleeding in the human body can occur in various situations, such as surgery, arterial puncture (arterial interventional diagnosis and interventional treatment), war injuries, and trauma in daily life. A large amount of blood loss in the human body can lead to serious consequences, even life-threatening. Uncontrolled blood loss from trauma is the second leading cause of civilian death in everyday life and the leading cause of death on the battlefield. Therefore, the research and development of hemostatic materials has always been the focus of attention at home and abroad. [0003] So far, in the treatment of surgical bleeding, the hemostatic materials used clinically are mainly degradable natural polymer derived materials, such as gelatin sponge, oxidized cellulose, microfibril collagen powder, fibrin ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61L15/28A61L15/42
CPCA61L24/0036A61L24/08A61L2400/04C08J3/24C08J2305/08C08L5/08
Inventor 黄山凌子胡碧煌
Owner LANZHOU KAIBO PHARMA
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com